Patterns of self‐monitoring of blood glucose in insulin‐treated diabetes: analysis of a <scp>S</scp>cottish population over time

Cameron, Dawn M; Harris, Fiona; Evans, Josie

doi:10.1111/dom.12662

Cited by 10 publications

(10 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These people are usually less motivated or more reluctant of using the often‐considered hassle and inconvenient conventional BGM. A population‐based study even lately indicated that up to 1‐third of individuals with type 1 diabetes do perform no BGM at all . Our study conducted in real‐life conditions therefore suggests that the access to the FGM technology tends to improve the willingness of individuals with poor glycaemic control to better take care of the disease.…”

Section: Discussionmentioning

confidence: 75%

The new FreeStyle libre flash glucose monitoring system improves the glycaemic control in a cohort of people with type 1 diabetes followed in real‐life conditions over a period of one year

Pâris

Henry

Pirard

et al. 2018

Endocrino Diabet & Metabol

View full text Add to dashboard Cite

SummaryAims: Using the novel FreeStyle Libre (FSL), glucose monitoring (FGM) system becomes increasingly popular among people with type 1 diabetes (T1D) and is associated with less and shorter hypoglycaemic events without deterioration of HbA1c.There are not yet data reporting the impact of FGM in people with T1D in real-life conditions. We sought of evaluating the tolerance, the acceptance and the efficacy of the FGM system in routine medical practice. Methods:This 12-month observational study included 120 individuals with T1D evaluated every 3 months. After having been instructed about FGM utilization, participants were trained to optimize the glycaemic control.Results: Participants stopped immediately of measuring capillary blood glucose (2.88 ± 0.12 per day) (mean ± SEM) after having received the first FSL device and the number of scans per day increased up to 8.87 ± 0.58 per day. HbA1c levels decreased from 8.51% ± 0.14% at baseline to 7.77% ± 0.09% after 3 months to slightly increase to 7.92% ± 0.09% at 12 months, in correlation with the number of scans per day. The number (but not the duration) of hypoglycaemic events slightly increased from 16.9 ± 1.44 per month at baseline to 24.0 ± 2.91 per month at 12 months, after reaching a peak of 26.4 ± 2.31 per month at 6 months. They were correlated with improved HbA1c. Conclusion:Our study shows that using the FGM system improves HbA1c levels in people with T1D along with a moderate increase in the number of mild hypoglycaemic events. The new FGM system facilitates the therapeutic empowerment of people with T1D, but in a context of structured education. K E Y W O R D Sdiabetes management, FreeStyle libre, glucose monitoring, real-life conditions

show abstract

Section: Discussionmentioning

confidence: 75%

The new FreeStyle libre flash glucose monitoring system improves the glycaemic control in a cohort of people with type 1 diabetes followed in real‐life conditions over a period of one year

Pâris

Henry

Pirard

et al. 2018

Endocrino Diabet & Metabol

View full text Add to dashboard Cite

show abstract

“…Recent population-based data indicate that day-to-day blood glucose testing frequency is low, with a mean number of test strips dispensed per day of 1.5 for insulin-treated Type 2 diabetes and 2.6 for Type 1 diabetes, with around one-third of individuals with Type 1 diabetes probably not testing at all [12]. These results support findings that up to 60% of drivers with diabetes never test their glucose level before driving and this low testing frequency has changed little in the last decade [5,6,13,14].…”

Section: What's New?mentioning

confidence: 99%

Could FreeStyle Libre^™ sensor glucose data support decisions for safe driving?

Rayman

Kröger²,

Bolinder

2017

Diabet. Med.

View full text Add to dashboard Cite

AimMany countries require individuals with diabetes to adhere to standards regarding blood glucose testing in order to be granted or retain a driving licence. Currently, interstitial glucose results may not be used. The aim of this study was to determine whether interstitial glucose measurements using flash glucose‐sensing technology can provide additional information to augment safe driving.MethodsSensor data from two European studies (NCT02232698 and NCT02082184) of the FreeStyle Libre Glucose Monitoring System™ in insulin‐treated Type 1 and Type 2 diabetes, 241 and 224 participants respectively, were used to determine the frequency of a low interstitial sensor glucose result (< 3.9 mmol/l) up to 4 h subsequent to a daytime (07:00–21:00 h) capillary blood glucose result ≥ 5 mmol/l.ResultsWithin 4 h of a capillary blood glucose result ≥ 5 mmol/l a sensor glucose result of < 3.9 mmol/l occurred on 22.0% of occasions (2573 of 11 706 blood glucose readings) for those with Type 1 diabetes, and 8.4% of occasions (699/8352) for those with Type 2 diabetes; 13.8% (1610/11 628) and 4.4% (365/8203) within 2 h, and 10.0% (1160/11 601) and 3.1% (254/8152) within 1.5 h. Analysis of sensor glucose results 5–7 mmol/l demonstrated the glucose trend arrow descending on 14.7% (1163/7894, Type 1 diabetes) and 9.4% (305/3233, Type 2 diabetes) of occasions.ConclusionsSensor‐based glucose information with directional arrows has the potential to support assessment of safe glucose levels associated with driving and offers distinct advantages over blood glucose testing for individuals with Type 1 and Type 2 diabetes to concord with driving safety standards.

show abstract

“…2 Despite growing evidence on the importance of SMBG as a key component of self-management, many people who are recommended to test routinely are not testing as frequently as recommended, and many are not testing at all. 3 There is also wide variation in individual practice of SMBG: frequency, timing, the measurement itself, interpretation of readings, resulting actions taken, and evaluation of the outcome. 4 These wide variations in practice may account for why clinical benefits identified from experimental studies that require SMBG to be undertaken according to strict protocols are often not replicated in observational studies.…”

Section: Introductionmentioning

confidence: 99%

Self-monitoring of blood glucose in insulin-treated diabetes: a multicase study

Cameron

Harris

Evans

2018

BMJ Open Diab Res Care

View full text Add to dashboard Cite

ObjectiveTo explore how and why self-monitoring of blood glucose (SMBG) is carried out in a real-world context.Research design and methodsWe conducted a multicase study among ten people with type 1 and insulin-treated type 2 diabetes mellitus in Scotland, alongside seven nominated support people and four healthcare professionals. All participants were interviewed in depth and six participants provided SMBG diaries. Stones’ version of structuration theory informed the analysis.ResultsPeople with diabetes were able to provide immediate motives for SMBG at particular times, often having different motives on different occasions. We identified six such motives, including routine, in response to symptoms, associated with a diabetes review, to facilitate lifestyle, when a ‘good’ result was expected, and higher level motives for longer term glycemic control. These motives were influenced by underlying attitudes toward diabetes that included level of engagement and responsibility for diabetes, a desire not to be controlled by diabetes, resistance to diabetes, diabetes education and relationship with the health service, fear of hypoglycemia, and prevention of diabetes complications. Five responses to test results were identified, depending on the immediate motive and underlying attitudes.ConclusionsPeople with insulin-treated diabetes do not necessarily self-monitor with an explicit goal of improving long-term glycemic control, but may have other motives that are important to them. An individualized understanding is therefore needed to advise people with diabetes how SMBG can be optimized for them.

show abstract

Patterns of self‐monitoring of blood glucose in insulin‐treated diabetes: analysis of a Scottish population over time

Cited by 10 publications

References 11 publications

The new FreeStyle libre flash glucose monitoring system improves the glycaemic control in a cohort of people with type 1 diabetes followed in real‐life conditions over a period of one year

The new FreeStyle libre flash glucose monitoring system improves the glycaemic control in a cohort of people with type 1 diabetes followed in real‐life conditions over a period of one year

Could FreeStyle Libre^™ sensor glucose data support decisions for safe driving?

Self-monitoring of blood glucose in insulin-treated diabetes: a multicase study

Contact Info

Product

Resources

About

Patterns of self‐monitoring of blood glucose in insulin‐treated diabetes: analysis of a Scottish population over time

Cited by 10 publications

References 11 publications

The new FreeStyle libre flash glucose monitoring system improves the glycaemic control in a cohort of people with type 1 diabetes followed in real‐life conditions over a period of one year

The new FreeStyle libre flash glucose monitoring system improves the glycaemic control in a cohort of people with type 1 diabetes followed in real‐life conditions over a period of one year

Could FreeStyle Libre™ sensor glucose data support decisions for safe driving?

Self-monitoring of blood glucose in insulin-treated diabetes: a multicase study

Contact Info

Product

Resources

About

Could FreeStyle Libre^™ sensor glucose data support decisions for safe driving?